---
title: "BGM Group Ltd. (BGM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BGM.US.md"
symbol: "BGM.US"
name: "BGM Group Ltd."
industry: "Pharmaceuticals"
datetime: "2026-06-10T02:41:56.086Z"
locales:
  - [en](https://longbridge.com/en/quote/BGM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BGM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BGM.US.md)
---

# BGM Group Ltd. (BGM.US)

## Company Overview

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.bgmgroupltd.com](https://www.bgmgroupltd.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1332.37 | - | - | - | - |
| PB | 0.34 | 10 | 9.79 | 6.70 | 0.47 |
| PS (TTM) | 76.60 | - | 76.60 | 76.60 | 76.60 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BGM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BGM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BGM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BGM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**